Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Microbiome, innate immunity, and esophageal adenocarcinoma.

About this Publication
Title
Microbiome, innate immunity, and esophageal adenocarcinoma.
Pubmed ID
25439272 (View this publication on the PubMed website)
Publication
Clin. Lab. Med. 2014 Dec; Volume 34 (Issue 4): Pages 721-32
Authors
Baghdadi J, Chaudhary N, Pei Z, Yang L
Affiliations
  • Department of Medicine, New York University School of Medicine, 550 1st Avenue, New York, NY 10016, USA.
  • Department of Medicine, New York University School of Medicine, 550 1st Avenue, New York, NY 10016, USA; Department of Veterans Affairs New York Harbor Healthcare System, 423 East 23rd street, New York, NY 10010, USA; Department of Pathology, New York University School of Medicine, 550 1st Avenue, New York, NY 10016, USA.
  • Department of Medicine, New York University School of Medicine, 550 1st Avenue, New York, NY 10016, USA. Electronic address: liying.yang@nyumc.org.
Abstract

With the development of culture-independent technique, a complex microbiome has been established and described in the distal esophagus. The incidence of esophageal adenocarcinoma (EAC) has increased dramatically in the United States. Studies documenting an altered microbiome associated with EAC and its precedents suggest that dysbiosis may be contributing to carcinogenesis, potentially mediated by interactions with toll-like receptors. Investigations attempting to associate viruses with EAC have not been as consistent. Currently available data are cross-sectional and therefore cannot prove causal relationships. Prospectively, microbiome studies open a new avenue to the understanding of the etiology and pathogenesis of reflux disorders and EAC.

Related CDAS Studies
Related CDAS Projects